JPWO2023171588A1 - - Google Patents
Info
- Publication number
- JPWO2023171588A1 JPWO2023171588A1 JP2024506296A JP2024506296A JPWO2023171588A1 JP WO2023171588 A1 JPWO2023171588 A1 JP WO2023171588A1 JP 2024506296 A JP2024506296 A JP 2024506296A JP 2024506296 A JP2024506296 A JP 2024506296A JP WO2023171588 A1 JPWO2023171588 A1 JP WO2023171588A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B25—HAND TOOLS; PORTABLE POWER-DRIVEN TOOLS; MANIPULATORS
- B25J—MANIPULATORS; CHAMBERS PROVIDED WITH MANIPULATION DEVICES
- B25J9/00—Programme-controlled manipulators
- B25J9/10—Programme-controlled manipulators characterised by positioning means for manipulator elements
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mechanical Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Robotics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022035641 | 2022-03-08 | ||
| PCT/JP2023/008202 WO2023171588A1 (ja) | 2022-03-08 | 2023-03-06 | 抗菌薬を含有するｐｌｇａ製剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2023171588A1 true JPWO2023171588A1 (en:Method) | 2023-09-14 |
Family
ID=87934986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024506296A Pending JPWO2023171588A1 (en:Method) | 2022-03-08 | 2023-03-06 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2023171588A1 (en:Method) |
| WO (1) | WO2023171588A1 (en:Method) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2308473A4 (en) * | 2008-07-01 | 2013-01-09 | Nitto Denko Corp | PHARMACEUTICAL COMPOSITION CONTAINING MICROPARTICLES WITH SURFACE COATING |
| ES2712779T3 (es) * | 2011-01-24 | 2019-05-14 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | Nanopartículas para la administración dérmica y sistémica de fármacos |
| JPWO2012169518A1 (ja) * | 2011-06-07 | 2015-02-23 | ホソカワミクロン株式会社 | 液状組成物及びそれを用いた化粧料並びに育毛剤 |
| NZ731955A (en) * | 2014-11-06 | 2023-07-28 | Xellia Pharmaceuticals Aps | Glycopeptide compositions |
| AU2016223090A1 (en) * | 2015-02-23 | 2017-08-24 | Cumberland Pharmaceuticals Inc. | Doses and methods of administering telavancin |
| CA3021935A1 (en) * | 2016-05-09 | 2017-11-16 | Xellia Pharmaceuticals Aps | Stabilized glycopeptide antibiotic formulations |
-
2023
- 2023-03-06 JP JP2024506296A patent/JPWO2023171588A1/ja active Pending
- 2023-03-06 WO PCT/JP2023/008202 patent/WO2023171588A1/ja active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023171588A1 (ja) | 2023-09-14 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20240815 |